| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |